140 related articles for article (PubMed ID: 9951404)
1. Syntheses and beta-adrenergic binding affinities of (R)- and (S)-fluoronaphthyloxypropanolamines.
Adejare A; Deal SA; Day MS
Chirality; 1999; 11(2):144-8. PubMed ID: 9951404
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and beta-adrenergic activities of R-fluoronaphthyloxypropanolamine.
Adejare A; Sciberras SS
Pharm Res; 1997 Apr; 14(4):533-6. PubMed ID: 9144745
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
Blanc M; Tamir A; Aubriot S; Michel MC; Bouzoubaa M; Leclerc G; Demenge P
J Med Chem; 1998 May; 41(10):1613-8. PubMed ID: 9572886
[TBL] [Abstract][Full Text] [Related]
7. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and first in vivo evaluation of new selective high affinity beta1-adrenoceptor radioligands for SPECT based on ICI 89,406.
Wagner S; Kopka K; Law MP; Riemann B; Pike VW; Schober O; Schäfers M
Bioorg Med Chem; 2004 Aug; 12(15):4117-32. PubMed ID: 15246089
[TBL] [Abstract][Full Text] [Related]
10. Stereospecific effects of benzo[d]isothiazolyloxypropanolamine derivatives at beta-adrenoceptors: synthesis, chiral resolution, and biological activity in vitro.
Comini M; Pozzoli C; Incerti M; Rossi D; Collina S; Azzolina O; Di Vittorio E; Morini G; Poli E
Chirality; 2009 Feb; 21(2):284-91. PubMed ID: 18537163
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
[TBL] [Abstract][Full Text] [Related]
13. Computer-aided mapping of the beta-adrenoceptor. 1. Explanation for effect of para substitution on blocking activity at the beta-1-adrenoceptor.
Ball JB; Nero TL; Iakovidis D; Tung L; Jackman G; Louis WJ
J Med Chem; 1992 Dec; 35(25):4676-82. PubMed ID: 1361581
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for enantiomer binding and separation of a common beta-blocker: crystal structure of cellobiohydrolase Cel7A with bound (S)-propranolol at 1.9 A resolution.
Ståhlberg J; Henriksson H; Divne C; Isaksson R; Pettersson G; Johansson G; Jones TA
J Mol Biol; 2001 Jan; 305(1):79-93. PubMed ID: 11114249
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, binding properties, and 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist.
Zheng L; Berridge MS; Ernsberger P
J Med Chem; 1994 Sep; 37(20):3219-30. PubMed ID: 7932549
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
Balsamo A; Gentili D; Lapucci A; Macchia M; Martinelli A; Orlandini E; Ferni G; Pinza M
Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
[TBL] [Abstract][Full Text] [Related]
17. Potent and selective human beta(3)-adrenergic receptor antagonists.
Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
[TBL] [Abstract][Full Text] [Related]
18. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
[TBL] [Abstract][Full Text] [Related]
19. Relationships between conformational behaviour and binding affinity towards beta 1 and beta 2 adrenoceptors of some chiral phenoxypropanolamines with bulky N-substituents.
Villa L; Villa AM; Pallavicini M; Romeo S; Valoti E; Ferri V; Iuliano E; Brunello N
Farmaco; 1995 Oct; 50(10):643-58. PubMed ID: 8590572
[TBL] [Abstract][Full Text] [Related]
20. [Blockers of beta-adrenergic receptors--a group of chiral agents stereoselective synthesis of beta-blockers].
Cizmáriková R; Valentová J; Hutt AJ; Sedláková S
Ceska Slov Farm; 2005 Sep; 54(5):201-6. PubMed ID: 16209433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
